CARE COORDINATION...

Pharos Innovations is a pioneer in the field of patient engagement and remote health status monitoring.  Pharos' solves the problem of avoidable hospital admissions and readmissions for those populations known to drive more than 70% of healthcare cost: individuals with chronic conditions, and those who are transitioning from one setting of care to another.  Through a set of technology based solutions, we help clients who are at clinical and financial risk consistently reduce readmissions by >60%, improve case loads for care coordinator by 3x, and increase patient satisfaction and loyalty. (LEARN MORE)

Our core enabling technology platform, called Tel-Assurance®, engages, motivates and drives improved self-care. Through Tel-Assurance, patients become active participants in their daily care, self-reporting their health status each day through the phone or Web. This unique approach actively engages them in their healthcare and provides care managers/nurses with real-time information to intervene before symptoms escalate. It is an effective, proven way to reduce avoidable hospital admissions and readmissions and overall healthcare costs among diverse populations.  (LEARN MORE)

Through over 6 years of clinical product development and validation, and another 8 years of commercial experience, Pharos has helped provider systems improve quality of their care management programs, and mak the shift from fee-for-service care models to those designed around population management and accountable care.  In fact, two of the 10 Physician Group Practice CMS Demonstration organizations chose Pharos Innovations as their partner for developing and achieving accountable care programs and results.  (LEARN MORE)

Today, the Tel-Assurance platform is used by "at risk" client organizations to manage populations with diabetes, heart failure, COPD/ Asthma, chronic pain, hypertension, high risk pregnancy, depression, post-traumatic stress disorder, and those undergoing care transitions post hospitalization.  (LEARN MORE)